What Healthy Med Spa Financials Look Like in 2026: A Benchmark Snapshot

A financially healthy medical spa in 2026 generates $1.39 million in annual revenue, runs at 38% net profit margin, retains 73% of patients for repeat visits, and keeps labor at or below 42% of revenue. Three primary-source benchmarks published in late 2025 and early 2026 converge on this profile.

A financially healthy medical spa in 2026 generates $1.39 million in annual revenue, runs at 38% net profit margin, retains 73% of patients for repeat visits, and keeps labor at or below 42% of revenue. Most single-location owners do not know which of those four numbers their practice is currently hitting.

This benchmark profile is derived from three independent primary sources published in late 2025 and early 2026: Growth99's 2026 State of Aesthetic and Elective Wellness Marketing Report (January 5, 2026), the Zenoti 2025 Beauty and Wellness Benchmark Report (March 9, 2026), and AMSPA's 2024 State of the Medical Spa Industry.

Each was compiled independently, from different methodologies and sample populations. The convergence on similar revenue and margin figures increases confidence in the benchmark range.

Revenue: what three 2026 sources show for average single-location practices

Three benchmarks from different methodologies converge in the $1 million to $1.4 million range for average single-location medical spa annual revenue.

Growth99's January 5, 2026 report, surveying 81 practice owners and managers, benchmarks "average med spa revenue: $1.39 million." AMSPA's 2024 State of the Industry survey reports "average annual revenue rose from $1,307,587 to $1,398,833" for the most recent survey year. Zenoti's platform data from 30,000+ businesses produces a lower figure at "$1,035,229 average medspa annual revenue per location," likely reflecting the inclusion of smaller and part-time practices in the platform data set.

The top 10% of practices in Zenoti's data reached $3,219,354 in annual revenue.

The gap between the median and the top decile, roughly $2.2 million in annual revenue, is not explained by a single variable. It reflects compounding operational advantages: higher utilization, better service mix, stronger membership programs, and accurate financial data that allows course corrections before margin problems compound.

38%
Average medical spa profit margin
Source: Growth99 2026 State of Aesthetic & Elective Wellness Marketing Report, January 5, 2026. Average annual revenue at same benchmark: $1.39 million. Repeat patient rate: 73%.

Profit margin: the 38% benchmark and the two cost lines that determine whether you hit it

Growth99's January 2026 report benchmarks average medical spa profit margins at 38%. AMSPA's data is consistent for well-run single-location practices. The 38% figure is net profit margin after all operating expenses including owner compensation at market rate.

Two cost lines determine whether a practice hits or misses this benchmark: labor and cost of goods sold (specifically injectables).

At average revenue of $1.39 million, a labor percentage above 42% alone is enough to compress net margin below 20% before accounting for rent, supplies, and device costs. Most practices that run below 20% net margin have at least one of: labor above 42%, unreconciled injectable COGS that understates the true cost of goods, or a device lease that is not generating enough revenue to cover its monthly payment.

The injectable COGS problem deserves specific attention. When a practice purchases Botox by the vial and bills by the unit, the gap between units purchased and units billed is the COGS reconciliation problem.

A practice that records injectable purchases as a lump supply expense and does not reconcile units against billings will systematically understate its true injectable COGS. The margin error is typically 12 to 18 percentage points on injectable services, which can represent $6,000 to $12,000 per month in overstated gross profit for a practice doing $50,000 in monthly injectable revenue.

Labor percentage: what happens above 42%

AMSPA benchmarks target labor at 35 to 42% of revenue for a healthy single-location practice. Labor includes all payroll, including front desk, providers, management, and owner compensation at a market replacement rate.

The 42% ceiling is not a soft guideline. It is the point above which, at average revenue levels, the remaining cost structure (rent, utilities, supplies, marketing, device leases) consumes the remaining margin and net profit falls below 10%.

The labor percentage problem at medical spas typically appears in one of two places: provider hours not matched to patient volume (high provider payroll relative to actual visit counts), or front desk and management headcount that has grown faster than revenue. Zenoti's data shows average staff utilization at 47%, meaning providers are billable for only 47% of their available time.

Top earners run 78% utilization. The 31-point utilization gap at average hourly provider cost translates directly into excess labor cost per revenue dollar.

Patient metrics: repeat rate, visit frequency, and average ticket

Growth99 and AMSPA both report a 73% repeat patient rate as the benchmark for healthy practices. AMSPA reports "average patient spend per visit: $527" and "monthly patient visits: 245 per location." Zenoti reports a lower average ticket of $164, again reflecting broader platform data including lower-volume appointment types.

Zenoti also reports "24% membership sales growth for salons, medspas, and waxing centers in 2024." Membership programs are growing as a share of med spa revenue because they address the single largest financial planning problem: revenue predictability.

A practice with 200 active members at $299 per month has a $59,800 predictable monthly revenue base before any fee-for-service appointments. That predictability changes how fixed cost decisions are made.

Metric Benchmark Source
Annual Revenue $1.39M (avg) Growth99 Jan 2026
Annual Revenue $1,035,229 (platform avg) Zenoti 2025
Annual Revenue $1,398,833 (survey avg) AMSPA 2024
Net Profit Margin 38% Growth99 Jan 2026
Repeat Patient Rate 73% Growth99 Jan 2026 / AMSPA 2024
Average Visit Spend $527 AMSPA 2024
Average Ticket $164 Zenoti 2025
Monthly Visits 245 per location AMSPA 2024
Target Labor % 35–42% AMSPA benchmark
Staff Utilization (avg) 47% Zenoti 2025
Staff Utilization (top 10%) 78% Zenoti 2025
Membership Growth 24% YoY (2024) Zenoti 2025

Five benchmark questions most owners cannot answer from their current P&L

The benchmarks above are only useful if a practice can measure its own performance against them. Most owners using a standard QuickBooks setup with a general bookkeeper cannot answer these five questions without a significant manual effort:

  1. 1
    What is your injectable gross margin after reconciling actual units consumed? Not the blended service margin. The injectable margin after matching product purchases to billed units.
  2. 2
    What is your labor percentage this month, including owner compensation at market rate? Not just payroll taxes paid. The full replacement cost of the owner's role in the practice.
  3. 3
    What is your current deferred revenue balance? The total value of packages and memberships sold but not yet redeemed, sitting on the balance sheet as a liability.
  4. 4
    What is your revenue per available provider hour? Not revenue per visit. Revenue divided by total scheduled provider hours, capturing the utilization gap.
  5. 5
    What is your device-specific contribution margin? Revenue generated by each device minus the direct costs assigned to it (consumables, maintenance, lease payment), expressed as a percentage of that device's revenue.
  6. 6
    What is your membership retention rate over the trailing 12 months? Members at the start of the period minus cancellations, divided by starting count. Below 80 percent is a program-design problem, not a market problem.

Worked example: benchmarking a $1.1M practice against the $1.39M target

Practice A: $1.1M revenue, 22 percent net margin, 46 percent labor, injectable COGS not reconciled.

Gap to the $1.39M benchmark: $290K in annual revenue. Gap to the 38 percent margin benchmark: 16 points, or $176K on current revenue.

Where the 16-point margin gap sits: 4 points in labor (46% vs 42% target = $44K), 8 points in understated injectable COGS ($88K the P&L never captured), 4 points in untracked device contribution ($44K in lease payments without matching revenue accountability). Closing the three lines adds $176K to the P&L before any revenue growth. The $290K revenue gap is a secondary fix.

Common mistake: benchmarking against revenue before fixing margin

Owners who see $1.39 million as the target push on marketing spend and injector headcount to close the revenue gap. The margin math gets worse, not better, because the same structural problems (labor percentage, unreconciled injectable COGS, device utilization) scale with revenue. A practice at $1.1 million with a 16-point margin gap becomes a practice at $1.4 million with the same 16-point margin gap, except now the dollar loss is bigger. Fix margin structure first. Revenue growth compounds cleanly only on a clean cost base.

All five of these are standard outputs from a properly structured medical spa financial setup. None requires switching software. All require a chart of accounts and a weekly reporting workflow designed specifically for the medical spa revenue model.

"65% of practices expect revenue growth in 2026.", Growth99 2026 State of Aesthetic & Elective Wellness Marketing Report, January 5, 2026

How to audit your books against these benchmarks

The audit has four components, each requiring data from QuickBooks and the practice's booking system:

Revenue audit: Pull total revenue for the trailing 12 months and annualize. Compare to the $1.39 million benchmark. If revenue is below $800,000 and the practice is more than two years old, the gap is more likely a service mix and pricing issue than a volume issue. Revenue per visit should be compared to the $527 AMSPA benchmark.

Margin audit: Pull net income as a percentage of revenue for the trailing 12 months. Below 25% net margin at average revenue levels indicates a cost structure problem. Identify which line items are out of range: labor above 42%, injectable COGS understated, or device costs not generating sufficient return.

Labor audit: Divide total payroll expense (all roles) by total revenue for the same period. Include owner draws converted to market-rate salary. If the result exceeds 42%, identify whether the driver is provider headcount or administrative headcount, as the remedies differ.

Patient metrics audit: Pull monthly visit counts and repeat patient percentage from the booking system for the trailing 12 months. Compare to 245 monthly visits and 73% repeat rate. Below 73% repeat rate at a practice older than 18 months typically reflects a patient retention problem, not a service quality problem. Pricing, rebooking protocols, and membership penetration are the levers.

The Spa Ledger calculators are built around these four audit components. Each calculator takes inputs from a practice's actual data and returns a benchmark comparison with context for what the gap means operationally. The EBITDA glossary entry explains how the profit margin benchmark relates to business valuation for owners considering a sale or acquisition in the next three to five years. For a deeper look at the margin benchmarks specifically, see the Med Spa Profit Margin Benchmarks post.

We run this benchmark audit in the first two weeks.

Revenue by service line, injectable COGS, labor percentage by role, and deferred membership balance, compared against industry benchmarks so you know exactly where you stand.

Reserve Your First Month

Frequently asked questions about med spa financial benchmarks

Growth99's January 2026 report, based on a survey of 81 practice owners and managers, benchmarks average medical spa profit margins at 38 percent. AMSPA's 2024 data is consistent with this for well-run single-location practices. Practices below 20 percent net margin typically have one or more of: labor above 42 percent of revenue, unreconciled injectable COGS, or a device lease not breaking even.
Three benchmarks from 2025-2026 sources converge in the $1 million to $1.4 million range for average single-location practices: Zenoti at $1,035,229, Growth99 at $1.39 million, and AMSPA at $1,398,833. Top 10% of Zenoti's sample reached $3,219,354. Revenue targets are more useful when set by service line, injectable revenue, device revenue, and retail, rather than as a single blended figure.
Divide total payroll (all staff, all roles, including owner compensation at market rate) by total revenue for the same period. Above 42 percent consistently compresses net margin below 10 percent at average revenue levels. Run this calculation monthly to catch drift before it compounds.
A 73% repeat rate means nearly three-quarters of your monthly visit volume comes from patients who have been to the practice before. The revenue risk is concentrated in acquisition, not retention. From a financial planning perspective, the baseline monthly revenue from returning patients is relatively predictable, which allows more confident fixed cost planning.
Zenoti's 2025 data shows an average ticket of $164 for average practices and higher for top earners. AMSPA's per-visit spend benchmark is $527. The discrepancy is likely because Zenoti's "ticket" includes all appointment types while AMSPA's measures total patient spend per visit including retail. Both are useful. The operational metric to watch is whether your average ticket is moving up or down month over month.
Quarterly is the minimum. Monthly is better for fast-moving practices. The benchmarks above are annual figures from 2024-2026 surveys, they do not change month to month. What changes is your practice's performance relative to them. A quarterly review asks: is my labor percentage moving toward or away from 42 percent? Is my injectable margin closer to 60-70 percent now that COGS is reconciled? Is my net margin above or below 38 percent?